BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21880184)

  • 1. Overexpression of centromere protein H is significantly associated with breast cancer progression and overall patient survival.
    Liao WT; Feng Y; Li ML; Liu GL; Li MZ; Zeng MS; Song LB
    Chin J Cancer; 2011 Sep; 30(9):627-37. PubMed ID: 21880184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
    He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
    Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression.
    Liao WT; Yu CP; Wu DH; Zhang L; Xu LH; Weng GX; Zeng MS; Song LB; Li JS
    J Exp Clin Cancer Res; 2009 Jun; 28(1):74. PubMed ID: 19500341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
    Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma.
    Cao JY; Liu L; Chen SP; Zhang X; Mi YJ; Liu ZG; Li MZ; Zhang H; Qian CN; Shao JY; Fu LW; Xia YF; Zeng MS
    Mol Cancer; 2010 Sep; 9():237. PubMed ID: 20828406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.
    O'Brien SL; Fagan A; Fox EJ; Millikan RC; Culhane AC; Brennan DJ; McCann AH; Hegarty S; Moyna S; Duffy MJ; Higgins DG; Jirström K; Landberg G; Gallagher WM
    Int J Cancer; 2007 Apr; 120(7):1434-43. PubMed ID: 17205517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer.
    McGovern SL; Qi Y; Pusztai L; Symmans WF; Buchholz TA
    Breast Cancer Res; 2012 May; 14(3):R72. PubMed ID: 22559056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival.
    Lu G; Shan T; He S; Ren M; Zhu M; Hu Y; Lu X; Zhang D
    Oncol Rep; 2013 Nov; 30(5):2238-44. PubMed ID: 23970101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of Centromere protein H expression in esophageal carcinoma.
    Guo XZ; Zhang G; Wang JY; Liu WL; Wang F; Dong JQ; Xu LH; Cao JY; Song LB; Zeng MS
    BMC Cancer; 2008 Aug; 8():233. PubMed ID: 18700042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival.
    Li J; Zhang N; Song LB; Liao WT; Jiang LL; Gong LY; Wu J; Yuan J; Zhang HZ; Zeng MS; Li M
    Clin Cancer Res; 2008 Jun; 14(11):3319-26. PubMed ID: 18519759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of centromere protein H and Ki67 in relapse-free survival of patients after primary surgery for hypopharyngeal cancer.
    Wang JX; Zhang YY; Yu XM; Jin T; Pan XL
    Asian Pac J Cancer Prev; 2012; 13(3):821-5. PubMed ID: 22631655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance and therapeutic implications of centromere protein F expression in patients with esophageal squamous cell carcinoma.
    Mi YJ; Gao J; Xie JD; Cao JY; Cui SX; Gao HJ; Yao SP; Liu T; Zhang YY; Guo CH; Qiu GQ; Chen YQ
    Dis Esophagus; 2013 Aug; 26(6):636-43. PubMed ID: 23163484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of CENP-H gene in human oral squamous cell carcinomas harboring high-proliferative activity.
    Shigeishi H; Higashikawa K; Ono S; Mizuta K; Ninomiya Y; Yoneda S; Taki M; Kamata N
    Oncol Rep; 2006 Nov; 16(5):1071-5. PubMed ID: 17016595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic significance of centromere protein A in human lung adenocarcinoma.
    Wu Q; Qian YM; Zhao XL; Wang SM; Feng XJ; Chen XF; Zhang SH
    Lung Cancer; 2012 Aug; 77(2):407-14. PubMed ID: 22542705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of centromere protein H in human gastric cancer cell proliferation].
    Quan T; He B; Liu T; Li W; Wu S; Jiang Q; Liu W; Liu H; Xu X
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):265-9. PubMed ID: 22381774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer.
    Ueda S; Kondoh N; Tsuda H; Yamamoto S; Asakawa H; Fukatsu K; Kobayashi T; Yamamoto J; Tamura K; Ishida J; Abe Y; Yamamoto M; Mochizuki H
    BMC Cancer; 2008 Dec; 8():384. PubMed ID: 19102762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
    Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
    Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth.
    Li Y; Zhu Z; Zhang S; Yu D; Yu H; Liu L; Cao X; Wang L; Gao H; Zhu M
    PLoS One; 2011 Mar; 6(3):e17794. PubMed ID: 21423629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
    Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
    BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.